Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1821-1830 of 2869 for cancer

Edit search filters
  1. Specialized Radiation Therapy And Chemotherapy In Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Suppression Of Ovarian Function With Either Tamoxifen Or Exemestane Compared With Tamoxifen Alone In Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    Eau Claire, WI

  3. COlorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment Of Liver Metastases In A Randomized, Double-blind, Placebo‑Controlled Phase-III STudy

    Rochester, MN

  4. A Study Of Rucaparib In Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer (ARIEL2)

    Jacksonville, FL, Rochester, MN

  5. Phase III Open Label Study Of MEDI 4736 With/Without Tremelimumab Versus Standard Of Care (SOC) In Recurrent/Metastatic Head And Neck Cancer

    Rochester, MN

  6. A Study To Evaluate Clinical Transplant-Related Long-term Outcomes Of Alternative Donor Allogeneic Transplantation

    Rochester, MN

  7. Study Of Safety And Efficacy Of Dapagliflozin + Metformin XR Versus Metformin XR In Participants With HR+, HER2-, Advanced Breast Cancer While On Treatment With Alpelisib And Fulvestrant

    Jacksonville, FL, Rochester, MN

  8. A Study To Evaluate The Effectiveness And Safety Of Rivaroxaban As Prophylaxis Treatment For Venous Thromboembolism (VTE) In Ambulatory Cancer Patients

    Rochester, MN

  9. A Study Of Pembrolizumab Alone Or Combined With CC-486 For Patients With Platinum-Resistant Ovarian, Fallopian Tube, Or Peritoneal Cancer

    Rochester, MN

  10. A Study For Women Who Have Platinum Resistant Ovarian Cancer To Evaluate EC145 Combined With Pegylated Liposomal Doxorubicin, Compared To Pegylated Liposomal Doxorubicin Alone

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer